The approach that LIFE takes with respect to improving patient outcomes is a holistic one, but tempered by the realities of each country and region. In some countries, certain fungal infections are common and the emphasis should be on these, and others are rare and are therefore secondary problems to be dealt with. Diagnosis is the cornerstone of good medicine and clinical care, and so this is the most urgent need.
LIFE is therefore flexible in its approach to achieving its overarching goals. However clinical expertise, and access to both diagnostic facilities and appropriate treatments are all critical to improving outcomes. Public awareness is also important specifically for some diseases such as SAFS and both skin and mucosal fungal infections. Public awareness and education about the problem will also allow a more sympathetic environment for implementation of care improvements.
LIFE’s approaches to addressing the diagnostic and treatment deficits are:
Awareness and Advocacy
Business engagement for sustainability
Competitions to drive creativity
Diagnostic development and dissemination
Education of healthcare professionals (development and support of national centres of excellence for local leadership)
Evaluation of efforts
LIFE will work with numerous partners especially through local (often national) ad hoc groups to further its aims.
Diagnosis – research resources
-
Title
Type